Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.18e-22	114	152	20	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.63e-21	124	152	20	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.88e-20	137	152	20	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.68e-17	192	152	20	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP17L7 USP17L21 USP17L4 TMPRSS15 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 ADAM7 USP17L24 USP17L5 USP17L10 USP17L19 PREPL USP17L18 USP17L17 LNPEP USP17L6P USP17L3 ADAMTS18 MMP1 USP17L22 USP17L15 USP17L8 USP17L13	4.33e-12	654	152	26	GO:0008233
GeneOntologyMolecularFunction	ferric-chelate reductase (NADPH) activity	STEAP1B STEAP1	5.67e-04	5	152	2	GO:0052851
GeneOntologyMolecularFunction	ferric-chelate reductase activity	STEAP1B STEAP1	5.67e-04	5	152	2	GO:0000293
GeneOntologyMolecularFunction	cupric reductase (NADH) activity	STEAP1B STEAP1	5.67e-04	5	152	2	GO:0008823
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.29e-21	125	152	20	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.32e-20	144	152	20	GO:0070646
GeneOntologyBiologicalProcess	post-translational protein modification	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 UBE3B UBR4 FN3KRP USP17L24 USP17L5 BIRC3 USP17L10 USP17L19 ASB15 DDB1 USP17L18 ARRB2 USP17L17 LNPEP DAW1 HACE1 SHPRH USP17L6P USP17L3 HERC1 MED23 USP17L22 USP17L15 USP17L8 USP17L13 LARGE1	3.51e-13	1074	152	34	GO:0043687
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 UBE3B UBR4 USP17L24 USP17L5 BIRC3 USP17L10 USP17L19 ASB15 DDB1 USP17L18 ARRB2 USP17L17 LNPEP DAW1 HACE1 SHPRH USP17L6P USP17L3 HERC1 MED23 USP17L22 USP17L15 USP17L8 USP17L13	1.89e-12	1009	152	32	GO:0070647
GeneOntologyCellularComponent	endoplasmic reticulum membrane	USP17L7 USP17L21 USP17L4 CYP2B6 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 TMEM39B USP17L10 USP17L19 GRM6 RTN1 USP17L18 ACSL3 SGMS1 USP17L17 USP17L6P USP17L3 ATL2 USP17L22 USP17L15 USP17L8 USP17L13	2.41e-06	1293	153	26	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	USP17L7 USP17L21 USP17L4 CYP2B6 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 TMEM39B USP17L10 USP17L19 GRM6 RTN1 USP17L18 ACSL3 SGMS1 USP17L17 USP17L6P USP17L3 ATL2 USP17L22 USP17L15 USP17L8 USP17L13	2.62e-06	1299	153	26	GO:0098827
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	USP17L7 USP17L21 USP17L4 CYP2B6 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 TMEM39B USP17L10 USP17L19 GRM6 RTN1 USP17L18 ACSL3 SGMS1 USP17L17 USP17L6P USP17L3 ATL2 USP17L22 USP17L15 USP17L8 USP17L13	3.86e-06	1327	153	26	GO:0042175
HumanPheno	Aplasia/Hypoplasia of the frontal sinuses	FLNA SMCHD1 DNAI1 ALX1	3.25e-05	16	62	4	HP:0009119
HumanPheno	Aplasia/Hypoplasia involving the sinuses	FLNA SMCHD1 DNAI1 ALX1	3.25e-05	16	62	4	HP:0009120
Domain	HABP4_PAI-RBP1	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	2.96e-28	16	150	14	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	2.96e-28	16	150	14	IPR006861
Domain	UCH	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	1.47e-22	71	150	18	PF00443
Domain	USP_2	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	1.47e-22	71	150	18	PS00973
Domain	USP_3	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	1.94e-22	72	150	18	PS50235
Domain	USP_dom	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	1.94e-22	72	150	18	IPR028889
Domain	Peptidase_C19_UCH	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	1.94e-22	72	150	18	IPR001394
Domain	USP_CS	USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	1.71e-21	66	150	17	IPR018200
Domain	USP_1	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	5.20e-21	70	150	17	PS00972
Domain	CPSF_A	DDB1 CPSF1	1.91e-04	3	150	2	PF03178
Domain	Cleavage/polyA-sp_fac_asu_C	DDB1 CPSF1	1.91e-04	3	150	2	IPR004871
Pathway	REACTOME_RAS_PROCESSING	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.15e-28	45	120	19	MM15671
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 BIRC3 USP17L10 USP17L19 USP17L18 ARRB2 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	8.48e-18	191	120	21	MM15289
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 BIRC3 USP17L10 USP17L19 USP17L18 ARRB2 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.51e-15	221	120	20	M27578
Pathway	REACTOME_DEUBIQUITINATION	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 BIRC3 USP17L10 USP17L19 USP17L18 ARRB2 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.48e-15	262	120	21	MM15286
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 ARRB2 USP17L17 PIK3CB USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.53e-13	318	120	21	MM15278
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 BIRC3 USP17L10 USP17L19 USP17L18 ARRB2 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.86e-13	299	120	20	M27574
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 FN3KRP USP17L5 BIRC3 USP17L10 USP17L19 DDB1 USP17L18 ARRB2 GLB1 USP17L17 ST6GALNAC3 SHPRH USP17L6P USP17L3 ADAMTS18 C3 USP17L22 USP17L15 USP17L8 USP17L13 LARGE1	3.82e-06	1389	120	29	MM15307
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 FN3KRP USP17L24 CAPZA1 USP17L5 BIRC3 USP17L10 USP17L19 ASB15 DDB1 USP17L18 ARRB2 GLB1 USP17L17 ST6GALNAC3 SHPRH USP17L3 ADAMTS18 C3 USP17L22 USP17L15 USP17L8 USP17L13 LARGE1	4.23e-06	1475	120	30	M19806
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.25e-43	21	154	19	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.25e-43	21	154	19	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.25e-43	21	154	19	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.25e-43	21	154	19	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.25e-43	21	154	19	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.25e-43	21	154	19	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	9.12e-43	22	154	19	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.50e-41	24	154	19	8995226
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.04e-40	25	154	19	21115691
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.84e-40	26	154	19	35816173
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.27e-39	33	154	20	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.07e-39	34	154	20	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.07e-39	34	154	20	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.07e-39	34	154	20	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.07e-39	34	154	20	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.07e-39	34	154	20	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.07e-39	34	154	20	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.07e-39	34	154	20	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.07e-39	34	154	20	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.07e-39	34	154	20	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.07e-39	34	154	20	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.07e-39	34	154	20	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.07e-39	34	154	20	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.15e-39	35	154	20	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.15e-39	35	154	20	21239494
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.16e-38	29	154	19	32527007
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.60e-38	36	154	20	20147298
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.47e-38	37	154	20	20228808
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.62e-32	50	154	19	31806660
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	5.49e-18	10	154	8	24207026
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	6.00e-17	12	154	8	24695638
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	3.61e-16	14	154	8	11793228
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	8.92e-15	19	154	8	28067227
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L7 USP17L21 USP17L4 CYP2B6 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.39e-11	674	154	20	37196079
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	3.01e-09	81	154	8	12838346
Pubmed	DNA sequence and analysis of human chromosome 8.	USP17L7 USP17L4 USP17L1 INTS1 USP17L3 USP17L8	7.19e-08	48	154	6	16421571
Pubmed	Embryonic demise caused by targeted disruption of a cysteine protease Dub-2.	USP17L2 USP17L15 USP17L13	3.39e-07	4	154	3	22984479
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	FLNA NAA15 KIF1A RPS6KA1 SMCHD1 UBR4 FN3KRP FARSB SIX4 DDB1 PREPL ACSL3 PTPRO LNPEP SNX27 C3 PADI2 DHX29	3.55e-07	974	154	18	28675297
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17	1.08e-06	119	154	7	28625976
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	FLNA KIF1A SMCHD1 UBR4 FN3KRP CAPZA1 FARSB BIRC3 DDB1 NDUFS3 ACSL3 SARS1 CDC40 SND1 CPSF1 CC2D2A MED23 ATL2 DHX29 NIPBL	5.32e-06	1425	154	20	30948266
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	USP17L7 IPPK DNAH3 USP17L12 KIF1A TOPAZ1 UBR4 INTS1 PCARE NDUFS3 SARS1 GLIPR1L2 USP17L3 CPSF1	5.51e-06	736	154	14	29676528
Pubmed	Sak serine-threonine kinase acts as an effector of Tec tyrosine kinase.	TEC PLK4	1.95e-05	2	154	2	11489907
Pubmed	Single-nucleotide polymorphisms in the lysyl oxidase-like protein 4 and complement component 3 genes are associated with increased risk for endometriosis and endometriosis-associated infertility.	LOXL4 C3	1.95e-05	2	154	2	21733505
Pubmed	KCNF1 promotes lung cancer by modulating ITGB4 expression.	ITGB4 KCNF1	1.95e-05	2	154	2	36385523
Pubmed	Isozyme-Specific Role of SAD-A in Neuronal Migration During Development of Cerebral Cortex.	BRSK2 BRSK1	1.95e-05	2	154	2	30307479
Pubmed	Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective.	C3 GPNMB	1.95e-05	2	154	2	28446616
Pubmed	TEC kinase stabilizes PLK4 to promote liver cancer metastasis.	TEC PLK4	1.95e-05	2	154	2	34637843
Pubmed	Inhibition of STEAP1 ameliorates inflammation and ferroptosis of acute lung injury caused by sepsis in LPS-induced human pulmonary microvascular endothelial cells.	STEAP1B STEAP1	1.95e-05	2	154	2	37209327
Pubmed	SAD: a presynaptic kinase associated with synaptic vesicles and the active zone cytomatrix that regulates neurotransmitter release.	BRSK2 BRSK1	1.95e-05	2	154	2	16630837
Pubmed	Investigating the regulation of brain-specific kinases 1 and 2 by phosphorylation.	BRSK2 BRSK1	1.95e-05	2	154	2	18339622
Pubmed	Absence of layer-specific cadherin expression profiles in the neocortex of the reeler mutant mouse.	PCDH11Y PCDH19 PCDH9	2.99e-05	14	154	3	20847152
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	FLNA NAA15 KIF1A SMCHD1 UBR4 INTS1 DDB1 ACSL3 SND1 CPSF1 DDX23 NIPBL	3.69e-05	653	154	12	22586326
Pubmed	Synapses of amphids defective (SAD-A) kinase promotes glucose-stimulated insulin secretion through activation of p21-activated kinase (PAK1) in pancreatic β-Cells.	BRSK2 BRSK1	5.83e-05	3	154	2	22669945
Pubmed	Inhibition of mouse RM-1 prostate cancer and B16F10 melanoma by the fusion protein of HSP65 & STEAP1 186-193.	STEAP1B STEAP1	5.83e-05	3	154	2	30841425
Pubmed	Lessons from genetic knockout mice deficient in neural recognition molecules.	MPZ ATP1B2	5.83e-05	3	154	2	7524110
Pubmed	PKD2 and RSK1 Regulate Integrin β4 Phosphorylation at Threonine 1736.	RPS6KA1 ITGB4	5.83e-05	3	154	2	26580203
Pubmed	Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins.	FLNA ARRB2	5.83e-05	3	154	2	16611986
Pubmed	Cadherin expression in the somatosensory cortex: evidence for a combinatorial molecular code at the single-cell level.	PCDH11Y PCDH9	5.83e-05	3	154	2	21129452
Pubmed	Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice.	STEAP1B STEAP1	5.83e-05	3	154	2	11479226
Pubmed	Persistence of the cell-cycle checkpoint kinase Wee1 in SadA- and SadB-deficient neurons disrupts neuronal polarity.	BRSK2 BRSK1	5.83e-05	3	154	2	20026642
Pubmed	Microtubule stabilization specifies initial neuronal polarization.	BRSK2 BRSK1	5.83e-05	3	154	2	18268107
Pubmed	G protein-coupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptor-filamin-beta-arrestin complex. A case of autoreceptor regulation.	FLNA ARRB2	5.83e-05	3	154	2	15687500
Pubmed	Six-transmembrane epithelial antigen of the prostate (STEAP1 and STEAP2)-differentially expressed by murine and human mesenchymal stem cells.	STEAP1B STEAP1	5.83e-05	3	154	2	19196137
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	UBR4 INTS1 PCDH19 HACE1 CC2D2A SYT4	6.46e-05	153	154	6	10718198
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	FLNA USP17L1 UBR4 FN3KRP CAPZA1 FARSB USP17L5 ACSL3 AGO1 SARS1 HMCN1 SND1 CPNE4	1.05e-04	844	154	13	25963833
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	FLNA NAA15 SMCHD1 UBR4 CAPZA1 FARSB DDB1 NDUFS3 ACSL3 ARRB2 CDC40 SND1 CPSF1 SNX27 DDX23 DHX29 NIPBL	1.11e-04	1353	154	17	29467282
Pubmed	Acute digoxin loading reduces ABCA8A mRNA expression in the mouse liver.	ABCA9 ABCA8	1.16e-04	4	154	2	16445568
Pubmed	CUL4A-DDB1-Rbx1 E3 ligase controls the quality of the PTS2 receptor Pex7p.	PEX7 DDB1	1.16e-04	4	154	2	24989250
Pubmed	Tuberous sclerosis complex proteins control axon formation.	BRSK2 BRSK1	1.16e-04	4	154	2	18794346
Pubmed	Mapping of synapsin II (SYN2) genes to human chromosome 3p and mouse chromosome 6 band F.	SYN2 ATP2B2	1.16e-04	4	154	2	7587399
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	FLNA SMCHD1 UBR4 FARSB SARS1 SND1 SNX27 NIPBL	1.24e-04	332	154	8	32786267
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	VWA3A CYP2B6 TMPRSS15 CYP11A1 UBE3B TIMMDC1 NDUFS3 AGO1 SGMS1 PIK3CB MANEAL CC2D2A HERC1 MED23 ATP2B2 UEVLD	1.34e-04	1242	154	16	30973865
Pubmed	beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53.	FLNA ARRB2	1.93e-04	5	154	2	17984062
Pubmed	The Steap proteins are metalloreductases.	STEAP1B STEAP1	1.93e-04	5	154	2	16609065
Pubmed	Evolutionary analysis of a cluster of ATP-binding cassette (ABC) genes.	ABCA9 ABCA8	1.93e-04	5	154	2	12532264
Pubmed	Foot pad skin biopsy in mouse models of hereditary neuropathy.	MPZ ITGB4	1.93e-04	5	154	2	20878767
Pubmed	The response of autologous T cells to a human melanoma is dominated by mutated neoantigens.	UBR4 GPNMB	1.93e-04	5	154	2	16247014
Pubmed	Physical and genetic maps of the deafwaddler region on distal mouse Chr 6.	SYN2 ATP2B2	1.93e-04	5	154	2	9615221
Pubmed	Cloning and characterization of a novel six-transmembrane protein STEAP2, expressed in normal and malignant prostate.	STEAP1B STEAP1	1.93e-04	5	154	2	12429817
Pubmed	Human SAD1 kinase is involved in UV-induced DNA damage checkpoint function.	BRSK2 BRSK1	1.93e-04	5	154	2	15150265
Pubmed	C-terminal phosphorylation of LKB1 is not required for regulation of AMP-activated protein kinase, BRSK1, BRSK2, or cell cycle arrest.	BRSK2 BRSK1	1.93e-04	5	154	2	18854318
Pubmed	ABC gene expression profiles have clinical importance and possibly form a new hallmark of cancer.	ABCA8 ABCC8	1.93e-04	5	154	2	28468577
Pubmed	Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.	VWA3A MPZ TRPC6 ADGRL4 SEMA3D PRELID2 ADAMTS18 MMP1 PADI2 DHX29 HYDIN	2.56e-04	686	154	11	29987050
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	NAA15 KIF1A SMCHD1 UBR4 FARSB AGO1 SNX27 C3 DHX29	2.83e-04	475	154	9	31040226
Pubmed	LKB1 and AMPK regulate synaptic remodeling in old age.	BRSK2 BRSK1	2.89e-04	6	154	2	25086610
Pubmed	Mammalian SAD kinases are required for neuronal polarization.	BRSK2 BRSK1	2.89e-04	6	154	2	15705853
Pubmed	Phosphorylation of microtubule-associated protein tau by AMPK-related kinases.	BRSK2 BRSK1	2.89e-04	6	154	2	21985311
Pubmed	The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex.	TRADD BIRC3	2.89e-04	6	154	2	8943045
Pubmed	Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1).	TRADD BIRC3	2.89e-04	6	154	2	18939944
Pubmed	SAD kinases control the maturation of nerve terminals in the mammalian peripheral and central nervous systems.	BRSK2 BRSK1	2.89e-04	6	154	2	24395778
Pubmed	A unified taxonomy for ciliary dyneins.	DNAI1 DAW1	2.89e-04	6	154	2	21953912
Pubmed	Identification of 14-3-3epsilon substrates from embryonic murine brain.	FLNA CAPZA1 BRSK2 SYN2 BRSK1	3.14e-04	132	154	5	16944949
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	TOPAZ1 DDB1 DNAI1 SARS1 SHPRH CPSF1 DDX23 HERC1 HYDIN	3.93e-04	497	154	9	36774506
Pubmed	RalA employs GRK2 and β-arrestins for the filamin A-mediated regulation of trafficking and signaling of dopamine D2 and D3 receptor.	FLNA ARRB2	4.03e-04	7	154	2	27188791
Pubmed	A class of dynamin-like GTPases involved in the generation of the tubular ER network.	RTN1 ATL2	4.03e-04	7	154	2	19665976
Pubmed	The structural genes encoding P450scc and P450arom are closely linked on mouse chromosome 9.	CYP11A1 GLB1	4.03e-04	7	154	2	2792009
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FLNA KIAA0513 UBE3B UBR4 INTS1 KDM3B LMTK2 ITGB4 SND1 NEK8 CPSF1 DEPDC5 HERC1 CABIN1	4.20e-04	1105	154	14	35748872
Pubmed	Context-specific function of the LIM homeobox 1 transcription factor in head formation of the mouse embryo.	PCDH11Y PCDH19 PCDH9	5.02e-04	35	154	3	25977363
Pubmed	MEGF10 and MEGF11 mediate homotypic interactions required for mosaic spacing of retinal neurons.	SEMA3D ABCC8 ADAMTS18	5.02e-04	35	154	3	22407321
Pubmed	TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis.	TRADD BIRC3	5.36e-04	8	154	2	19815541
Cytoband	4p16.1	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	1.29e-20	79	154	14	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.67e-14	222	154	14	chr4p16
Cytoband	8p23.1	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.44e-05	154	154	6	8p23.1
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.47e-04	234	154	6	chr8p23
GeneFamily	Non-clustered protocadherins	PCDH11Y PCDH19 PCDH9	2.46e-05	12	89	3	21
GeneFamily	Proteases, serine\|STEAP family	STEAP1B STEAP1	2.37e-04	5	89	2	1324
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	CPAMD8 C3	8.43e-04	9	89	2	1234
GeneFamily	ATP binding cassette subfamily A	ABCA9 ABCA8	2.10e-03	14	89	2	805
Coexpression	MADAN_DPPA4_TARGETS	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.44e-25	86	151	19	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.80e-23	112	151	19	MM1095
Coexpression	GERY_CEBP_TARGETS	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 C3 USP17L22 USP17L15 USP17L8 USP17L13	3.23e-21	160	151	20	MM1155
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 ITGB4 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 PADI2 USP17L15 USP17L8 USP17L13	1.65e-10	647	151	21	MM981
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	USP17L7 USP17L21 TRADD USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 UBE3B USP17L5 BIRC3 USP17L10 USP17L19 USP17L18 SARS1 CDC40 USP17L17 LNPEP USP17L6P USP17L3 HERC1 USP17L22 USP17L15 USP17L8 USP17L13	5.09e-10	1072	151	26	MM1031
Coexpression	BRUINS_UVC_RESPONSE_LATE	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 LMTK2 PEX7 USP17L5 USP17L10 USP17L19 ITGB4 NDUFS3 USP17L18 USP17L17 USP17L6P USP17L3 SMG9 SNX27 LRRC28 USP17L22 USP17L15 USP17L8 USP17L13	5.19e-09	1198	151	26	MM1062
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	USP17L7 IPPK USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 ITGB4 USP17L18 USP17L17 USP17L6P USP17L3 HERC1 USP17L22 PADI2 USP17L15 USP17L8 USP17L13	5.86e-07	1226	151	23	MM979
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#1_top-relative-expression-ranked_200	KCNF1 LNPEP SYN2 C3 OSMR	1.35e-05	50	130	5	gudmap_developingLowerUrinaryTract_adult_bladder_200_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#3_top-relative-expression-ranked_1000	MPZ BRSK2 RTN1 PTPRO SYN2 SYT4 ATP2B2	1.98e-05	135	130	7	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k3
CoexpressionAtlas	cerebral cortex	KIF1A KIAA0513 SMIM18 FRMPD2 PCDH11Y BRSK2 CHST1 RTN1 CRB1 NDST3 KCNF1 ABCC8 MANEAL PCDH19 SYN2 SYT4 CPNE4 BRSK1 ATP1B2 PADI2 ATP2B2 PCDH9	5.35e-05	1428	130	22	cerebral cortex
ToppCell	wk_15-18-Epithelial-PNS-KCNIP4+_neuron\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MPZ HTR3A KIF1A SMIM18 RTN1 SYN2 SYT4 ATP2B2	1.49e-07	179	147	8	e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a
ToppCell	PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	KIF1A BRSK2 RTN1 CRB1 PTPRO MANEAL SYN2 SYT4	1.77e-07	183	147	8	9dfb398b9995d562864fe688861a831ada0814cd
ToppCell	PCW_05-06-Neuronal-Neuronal_postreplicative\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	HTR3A KIF1A BRSK2 RTN1 CRB1 MANEAL SYN2 SYT4	1.92e-07	185	147	8	512f489daeb3b72d4578dc6f4d0ebb5f38d5bbab
ToppCell	IPF-Epithelial-Club\|Epithelial / Disease state, Lineage and Cell class	CPAMD8 CYP2B6 HMCN1 CELF2 ST6GALNAC3 C3 CPNE4 ATL2	2.55e-07	192	147	8	356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2
ToppCell	PND10-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP11A1 TEC GRM6 ADORA3 ARRB2 HERC1 PADI2	1.71e-06	172	147	7	c05af6e559f6af0fb15cefa03ffa1413e98a1a4a
ToppCell	PND10-Immune-Immune_Myeloid-Granulocytic-Basophil\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP11A1 TEC GRM6 ADORA3 ARRB2 HERC1 PADI2	1.71e-06	172	147	7	953b05f776348cff784e79c93df65841939d880f
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RTN1 ABCC8 MANEAL SYN2 SYT4 PLCXD3 CPNE4	2.00e-06	176	147	7	2e1003dc373b14d27f0464d980453fdcfc1005f0
ToppCell	wk_15-18-Epithelial-PNS-SST+_neuron\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	HTR3A KIF1A BRSK2 RTN1 ABCC8 SYT4 ATP2B2	2.50e-06	182	147	7	a7e77aaaddabf78c7784f72b3431703fc5ee4a8c
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VWA3A DNAH3 FRMPD2 UROC1 DNAI1 DAW1 HYDIN	2.68e-06	184	147	7	5daff849625f2f41d56615569c0ed59cd733b34c
ToppCell	5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HTR3A KIF1A SMIM18 RTN1 SYT4 PLCXD3 ATP2B2	2.88e-06	186	147	7	24b23880d4ff8fb4a23e2012d5890b9e2fcf7283
ToppCell	NS-moderate-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 CC2D2A HYDIN	2.88e-06	186	147	7	85787ff207f109ec7e3c0f729ba9bda739c2fdc9
ToppCell	droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMIM18 ITGB4 NDST3 ABCC8 BRSK1 ATP2B2 HYDIN	3.09e-06	188	147	7	ec0e241de2c8310b4417b9d4e2420d7a1662f1c0
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HTR3A KIF1A SMIM18 RTN1 ABCC8 PCDH19 SYT4	3.09e-06	188	147	7	bd091503f580dedab40e0996273101285d24b586
ToppCell	wk_15-18-Epithelial-PNS-PCP4+_neuron\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	HTR3A KIF1A SMIM18 RTN1 SYN2 SYT4 ATP2B2	3.20e-06	189	147	7	22c927d2691b867fbdee1fbee042a6d3f7eadd7d
ToppCell	wk_08-11-Epithelial-PNS-SST+_neuron\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	HTR3A KIF1A SMIM18 CHST1 RTN1 MANEAL SYT4	3.43e-06	191	147	7	df2bef74a54f4c23c99bd3b93225fd36bcd90723
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHST1 RTN1 KCNF1 SYN2 SYT4 CPNE4 ATP2B2	3.68e-06	193	147	7	be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCell	wk_15-18-Epithelial-PNS\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MPZ KIF1A SMIM18 RTN1 SYN2 SYT4 ATP2B2	3.68e-06	193	147	7	ca65f8f93058ad50d89e69e06c10deeb46dbfc87
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHST1 RTN1 KCNF1 SYN2 SYT4 CPNE4 ATP2B2	3.68e-06	193	147	7	0c652ebe22ce5d2927599dd97ef1920547858395
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHST1 RTN1 KCNF1 SYN2 SYT4 CPNE4 ATP2B2	3.68e-06	193	147	7	8689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 CC2D2A HYDIN	3.80e-06	194	147	7	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	moderate-Epithelial-Ciliated\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 CC2D2A HYDIN	3.94e-06	195	147	7	e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HTR3A KIF1A SMIM18 RTN1 ABCC8 PCDH19 SYT4	3.94e-06	195	147	7	5a6a5048af638872700b76b7c71a8fa3fb8d3772
ToppCell	NS-control-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 CC2D2A HYDIN	4.07e-06	196	147	7	d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a
ToppCell	distal-3-Epithelial-Proximal_Ciliated\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	VWA3A DNAH3 TCP11X2 FRMPD2 DNAI1 DAW1 HYDIN	4.21e-06	197	147	7	15b4d1203943ce90a7083178d4a4284d9b323071
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HTR3A KIF1A BRSK2 RTN1 ABCC8 MANEAL SYT4	4.21e-06	197	147	7	a07e1a9b95c9f8a09452cbfe5a9f06648f66e29e
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Cortical_neuron\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	SMIM18 RTN1 NDST3 CELF2 PTPRO SYT4 CPNE4	4.65e-06	200	147	7	44bc4d6616fc8d0ad8498e56125939034e8cff01
ToppCell	PND07-Immune-Immune_Myeloid-Granulocytic\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP11A1 TEC GRM6 ADORA3 ARRB2 PADI2	1.24e-05	154	147	6	f92d83c5f8b532fe5624f1cd352632f543d96ea9
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_4\|356C / Donor, Lineage, Cell class and subclass (all cells)	DNAH3 TRPC6 PEX7 CC2D2A GPNMB BRSK1	1.65e-05	162	147	6	7d43d59531cbefe3ac94953b7faf7156b2a31441
ToppCell	PND14-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP11A1 TEC GRM6 ADORA3 ARRB2 PADI2	1.77e-05	164	147	6	f4de9f18134a06f3d7fcf5b50b8e21c1506e2083
ToppCell	PND14-Immune-Immune_Myeloid-Granulocytic-Basophil\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP11A1 TEC GRM6 ADORA3 ARRB2 PADI2	1.77e-05	164	147	6	dc22b1fef49c1557a0b63c536eaba574dfcab715
ToppCell	PND07-Immune-Immune_Myeloid-Granulocytic-Basophil\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP11A1 TEC GRM6 ADORA3 ARRB2 PADI2	2.17e-05	170	147	6	bca78719c17355772ad6c53ee75e459faf1d089f
ToppCell	PND07-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP11A1 TEC GRM6 ADORA3 ARRB2 PADI2	2.17e-05	170	147	6	40d863554ec98ae43f76511c1112859688846613
ToppCell	PND01-Immune-Immune_Myeloid-Granulocytic-Basophil\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP11A1 TEC GRM6 ADORA3 ARRB2 PADI2	2.32e-05	172	147	6	6503e85182eb6e8a40a890e393e9ac5c5350e322
ToppCell	PND01-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP11A1 TEC GRM6 ADORA3 ARRB2 PADI2	2.32e-05	172	147	6	3c0bf7200e582ee730af49dcd86446e112226aca
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP11A1 GRM6 ADORA3 HYLS1 PADI2 TEC	2.55e-05	175	147	6	1b35acece23712ab7e3f92d9d68266efd38b3ef5
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP11A1 GRM6 ADORA3 HYLS1 PADI2 TEC	2.55e-05	175	147	6	a9f88054e2c28d604c65ed785f63021aadb7f4c8
ToppCell	3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HTR3A SMIM18 RTN1 SYT4 CPNE4 ATP2B2	2.64e-05	176	147	6	04dad262929581872e5bbc66cd8182c963e7e52f
ToppCell	droplet-Marrow-BM-30m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP11A1 GRM6 ADORA3 GLB1 PADI2 TEC	2.64e-05	176	147	6	8e4600efeea095a92178cfd26d7c58db7dfc0c80
ToppCell	PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MPZ KIF1A BRSK2 CRB1 PTPRO MANEAL	2.81e-05	178	147	6	38ffbd01230c99f52274424ee6c172381daffc73
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 PIEZO2 ALX1 PLCXD3 OSMR	2.81e-05	178	147	6	78a0c6340001a77f5b2d890b6263f574af2e72da
ToppCell	PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MPZ KIF1A BRSK2 CRB1 MANEAL SYN2	2.90e-05	179	147	6	df6d2cdc4e204ce1a4628dc71dfbc5e6c6309b2a
ToppCell	droplet-Marrow-nan-21m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP11A1 GRM6 ADORA3 ST6GALNAC3 PADI2 TEC	2.99e-05	180	147	6	41e8155cc7b3dac9d496e4077845ca6af1591a5c
ToppCell	368C-Epithelial_cells-Epithelial-F_(Ciliated)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	3.08e-05	181	147	6	5a4574f1bfd0b4ca78da7effda43420857e17296
ToppCell	368C-Epithelial_cells-Epithelial-F_(Ciliated)\|368C / Donor, Lineage, Cell class and subclass (all cells)	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	3.08e-05	181	147	6	a4e891603645f694687e68e585744ddc1a3c8697
ToppCell	droplet-Pancreas-Exocrine-18m-Endothelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA3A ADGRL4 HMCN1 ST6GALNAC3 PCDH19 OSMR	3.18e-05	182	147	6	3b4dbf61ca0fe50efe05449815630e301cb76630
ToppCell	droplet-Pancreas-Exocrine-18m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA3A ADGRL4 HMCN1 ST6GALNAC3 PCDH19 OSMR	3.18e-05	182	147	6	ab5761bf9af439231cd0f487b6467e372672a517
ToppCell	367C-Epithelial_cells-Epithelial-F_(Ciliated)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	3.28e-05	183	147	6	b1336eac5adbffade4cef3e0ce3de75a781ae365
ToppCell	367C-Epithelial_cells-Epithelial-F_(Ciliated)\|367C / Donor, Lineage, Cell class and subclass (all cells)	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	3.28e-05	183	147	6	cc57dcb59c68d68a546dc108dd9e009b2aab8da5
ToppCell	PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HTR3A SMIM18 RTN1 MANEAL SYN2 SYT4	3.38e-05	184	147	6	571136c832cb8c08457744152231537aa8e8abd7
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPC6 DNAI1 PIEZO2 KCNF1 ATP1B2 HYDIN	3.38e-05	184	147	6	1c857126c0ea0671f0d60b048efca288d348d653
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HTR3A KIF1A SMIM18 RTN1 MANEAL SYN2	3.48e-05	185	147	6	3d6711030ca4328357b06d5497cf98cdefcd7f4f
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Adult / Lineage, Cell type, age group and donor	CPAMD8 CYP2B6 CYP11A1 ST6GALNAC3 ATL2 PCDH9	3.48e-05	185	147	6	673f0c688ae6984bc8027df2da335787924f4137
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	VWA3A DNAH3 FRMPD2 DNAI1 CC2D2A HYDIN	3.48e-05	185	147	6	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	VWA3A DNAH3 FRMPD2 UROC1 DNAI1 HYDIN	3.48e-05	185	147	6	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	18-Distal-Epithelial-Epithelial\|Distal / Age, Tissue, Lineage and Cell class	MPZ HTR3A KIF1A RTN1 MANEAL SYT4	3.48e-05	185	147	6	d2a266724f3f70f746a78034f308d98f8b7a66e3
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	3.48e-05	185	147	6	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HTR3A SMIM18 RTN1 SYT4 CPNE4 ATP2B2	3.48e-05	185	147	6	edb114487206e4e8df4c7878285df40f49b7fd64
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0513 BRSK2 RTN1 ABCC8 SYT4 PLCXD3	3.59e-05	186	147	6	d1d01ce46e62944aa9864eda47e8401b5f0d2bdc
ToppCell	PCW_07-8.5-Neuronal\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MPZ HTR3A BRSK2 CRB1 SYN2 SYT4	3.59e-05	186	147	6	7a4bb42f3f6a27b463e48eafc587d9ab3386f2fb
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ITGB4 ADGRL4 ST6GALNAC3 ABCC8 PLCXD3 OSMR	3.70e-05	187	147	6	e35716f8b482be3bf5ab79f087a9caf67a9d197a
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ABCA9 ABCA8 ALX1 PLCXD3 OSMR LARGE1	3.70e-05	187	147	6	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MPZ ARMCX5 NDST3 BRSK1 ATP1B2 PCDH9	3.70e-05	187	147	6	8e8b147258982b359447add5027318f5b6d51963
ToppCell	21-Trachea-Epithelial-Intermediate_ciliated\|Trachea / Age, Tissue, Lineage and Cell class	VWA3A FRMPD2 DNAI1 DAW1 CC2D2A HYDIN	3.70e-05	187	147	6	1a2178a195d078d1963947b327c6d0d4f2f48341
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	3.81e-05	188	147	6	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	3.81e-05	188	147	6	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	COVID-19-lung-Ciliated\|COVID-19 / Disease (COVID-19 only), tissue and cell type	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	3.93e-05	189	147	6	a2da5debd10f27b1280b40141ef0bfef007cc72c
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	3.93e-05	189	147	6	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	3.93e-05	189	147	6	dc440015949a768188c67661b6be63b1ead1a0f0
ToppCell	Endothelial-endothelial_cell_of_artery\|World / Lineage, Cell type, age group and donor	CPAMD8 ITGB4 ADGRL4 HMCN1 ST6GALNAC3 PLCXD3	3.93e-05	189	147	6	fdd89c71113ac99b7c800c6def8888e512ff1128
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	3.93e-05	189	147	6	a3cd4c2da4feb9bdcd8957f3e344d095da1367b8
ToppCell	Multiciliated\|World / shred by cell class for nasal brushing	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	3.93e-05	189	147	6	34b110aef839376228c5a403a6b5047a945f472b
ToppCell	Adult-Epithelial-ciliated_cell\|Adult / Lineage, Cell type, age group and donor	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	3.93e-05	189	147	6	b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	3.93e-05	189	147	6	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	E12.5-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MPZ HTR3A SMIM18 RTN1 NDST3 SYT4	3.93e-05	189	147	6	620d30bb6211fff6adab0638d0d994f547167a29
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	3.93e-05	189	147	6	93b1026bb1ba759e5704561c9a5de14a30c08894
ToppCell	Ciliated_cells-B\|World / lung cells shred on cell class, cell subclass, sample id	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	4.04e-05	190	147	6	7031fbedc13be1a00f6333ad6d51849c3739c2e6
ToppCell	PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	HTR3A KIF1A SMIM18 RTN1 MANEAL SYT4	4.16e-05	191	147	6	3a5081dc542ac6262acfe5f8084a86616fee8082
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	4.16e-05	191	147	6	2a8e6d560907e71e9f6e190ca0667da804e25641
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	4.16e-05	191	147	6	46c9d4d10c66c0fae1fa351924091b69ea2f38d4
ToppCell	Control-Epithelial-Ciliated_cells\|Control / Condition, Lineage and Cell class	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	4.16e-05	191	147	6	ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCell	Mild_COVID-19-Epithelial-Ciliated\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	4.16e-05	191	147	6	995e76bbf07674d95b8ef09e078cf6410af27a09
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	4.16e-05	191	147	6	a37f20172b85566b9039254a89680e37fd503fd5
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	4.16e-05	191	147	6	2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d
ToppCell	Control-Epithelial\|Control / Condition, Lineage and Cell class	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	4.16e-05	191	147	6	6228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCell	IPF-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	4.29e-05	192	147	6	d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11
ToppCell	IPF-Epithelial-Ciliated\|IPF / Disease state, Lineage and Cell class	VWA3A DNAH3 FRMPD2 DNAI1 DAW1 HYDIN	4.29e-05	192	147	6	354adc1354bf596fbc60dd45c0169688e6f45165
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ITGB4 ADGRL4 ST6GALNAC3 ABCC8 PLCXD3 OSMR	4.41e-05	193	147	6	9ba688b35a9ead5d04691b3f3f15484f02dbbd0d
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRL4 SEMA3D HMCN1 CASKIN2 ST6GALNAC3 ADAMTS18	4.41e-05	193	147	6	1f978e102a029a6beb10913052cd0a20c7253e8e
ToppCell	Adult-Endothelial\|Adult / Lineage, Cell type, age group and donor	ADGRL4 SEMA3D CASKIN2 ST6GALNAC3 SYN2 PLCXD3	4.54e-05	194	147	6	963b3fbee0575af8379baa397ace65949eaf34f7
ToppCell	18-Airway-Epithelial-Epithelial\|Airway / Age, Tissue, Lineage and Cell class	MPZ HTR3A KIF1A SMIM18 RTN1 SYT4	4.54e-05	194	147	6	d3c90e1f1228f8ba0ba56105c6cf4f302c388f28
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	VWA3A DNAH3 FRMPD2 DNAI1 CC2D2A HYDIN	4.67e-05	195	147	6	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	critical-Epithelial-Ciliated\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH3 FRMPD2 DNAI1 DAW1 CC2D2A HYDIN	4.81e-05	196	147	6	27b855c6e1ae44f16db998cf0e81bd686b9cee7e
ToppCell	wk_08-11-Epithelial-PNS-TM4SF4+_PENK+_neuron\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	HTR3A KIF1A SMIM18 CHST1 RTN1 SYT4	4.81e-05	196	147	6	afa3a2f5f3a51d1830c6f95f97a4b3e13ed42512
ToppCell	primary_visual_cortex-Neuronal\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KIF1A RTN1 PREPL SYN2 SYT4 ATP2B2	4.81e-05	196	147	6	8efc2b3a95f57c31be203ac781b2098d4909297f
ToppCell	frontal_cortex-Neuronal\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KIF1A RTN1 PREPL SYN2 SYT4 ATP2B2	4.81e-05	196	147	6	de7d10da862f98894ce47244fbc992f4a12d63bb
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KIF1A SMIM18 RTN1 ABCC8 MANEAL SYT4	4.95e-05	197	147	6	27c044833e471a312a572e0b1c83e4bc8a36e896
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA9 ABCA8 SEMA3D C3 ATP1B2 STEAP1	4.95e-05	197	147	6	31c8d6e565bbdc37843ce871fe91845b0cc18a9f
ToppCell	control-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	VWA3A DNAH3 FRMPD2 DAW1 CC2D2A HYDIN	4.95e-05	197	147	6	e453d085182364ca347cbcc9dc995c62c3353016
ToppCell	control-Epithelial-Ciliated\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	VWA3A DNAH3 FRMPD2 DAW1 CC2D2A HYDIN	4.95e-05	197	147	6	d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VWA3A DNAH3 DNAI1 DAW1 HYLS1 PLK4	5.09e-05	198	147	6	f31790442ef142f1c0c49bf3daf2d0efb193d2c9
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.00e-34	46	146	20	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L7 USP17L21 USP17L4 NAA15 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.89e-32	69	146	21	DOID:1682 (implicated_via_orthology)
Disease	Intellectual Disability	NAA15 BRSK2 KDM3B FARSB UROC1 PREPL AGO1 SNX27 SERAC1 MED23 LARGE1	1.49e-05	447	146	11	C3714756
Disease	serine/threonine-protein kinase BRSK2 measurement	BRSK2 BRSK1	7.27e-05	3	146	2	EFO_0803063
Disease	tyrosine-protein kinase TEC measurement	TEC TEC	1.45e-04	4	146	2	EFO_0020830
Disease	childhood trauma measurement	NDST3 ST6GALNAC3 PCDH9	2.23e-04	24	146	3	EFO_0007979
Disease	Ciliopathies	PCARE CRB1 NEK8 HYLS1 CC2D2A	2.23e-04	110	146	5	C4277690
Disease	depressive symptom measurement	TOPAZ1 UBE3B CRB1 ADGRL4 CELF2 SYN2 HERC1 PCDH9 LARGE1	2.84e-04	426	146	9	EFO_0007006
Disease	Global developmental delay	INTS1 BRSK2 KDM3B AGO1 SNX27	5.35e-04	133	146	5	C0557874
Disease	Colorectal Carcinoma	DNAH3 CPAMD8 FRMPD2 ABCA9 ABCA8 NDST3 ADORA3 ABCC8 ADAMTS18 MMP1 GPNMB	7.69e-04	702	146	11	C0009402
Disease	Seizures	CYP11A1 KDM3B GLB1 HACE1 SYN2 SNX27	7.80e-04	218	146	6	C0036572
Disease	visceral heterotaxy (implicated_via_orthology)	DNAI1 DAW1 CC2D2A	8.15e-04	37	146	3	DOID:0050545 (implicated_via_orthology)
Disease	overall survival	OSMR PCDH9	8.56e-04	9	146	2	EFO_0000638
Disease	Retinal Detachment	CPAMD8 CRB1	1.30e-03	11	146	2	C0035305
Disease	sciatic neuropathy (biomarker_via_orthology)	MPZ CYP11A1 ABCC8 C3	1.50e-03	99	146	4	DOID:11446 (biomarker_via_orthology)
Disease	temporal pole volume measurement	PTPRO SYT4	1.55e-03	12	146	2	EFO_0010334
Disease	tyrosine-protein kinase ZAP-70 measurement	C3 PLCXD3	1.55e-03	12	146	2	EFO_0020833
Disease	Hereditary Motor and Sensory-Neuropathy Type II	MPZ KIF1A	1.83e-03	13	146	2	C0270914
Disease	Kartagener syndrome (implicated_via_orthology)	DNAI1 DAW1	2.13e-03	14	146	2	DOID:0050144 (implicated_via_orthology)
Disease	3-hydroxyphenylacetic acid measurement	PIEZO2 STEAP1B	2.13e-03	14	146	2	EFO_0010448
Disease	wellbeing measurement	UBE3B ADGRL4 SGMS1 CELF2 SND1 SYN2 LRRC28 HERC1 PCDH9 LARGE1	2.41e-03	692	146	10	EFO_0007869
Disease	Generalized hypotonia	AGO1 SNX27	2.45e-03	15	146	2	C1858120
Disease	Colorectal Neoplasms	CPAMD8 ABCA9 ABCA8 ABCC8 MMP1 GPNMB	2.63e-03	277	146	6	C0009404
Disease	Spondyloepiphyseal Dysplasia	FLNA GLB1	2.79e-03	16	146	2	C0038015
Disease	Spondyloepiphyseal Dysplasia Tarda, X-Linked	FLNA GLB1	2.79e-03	16	146	2	C3541456
Disease	Schwartz-Jampel Syndrome, Type 1	FLNA GLB1	2.79e-03	16	146	2	C4551479
Disease	Abnormal behavior	BRSK2 KDM3B	2.79e-03	16	146	2	C0233514
Disease	Schwartz-Jampel Syndrome	FLNA GLB1	2.79e-03	16	146	2	C0036391
Disease	Melnick-Needles Syndrome	FLNA GLB1	2.79e-03	16	146	2	C0025237
Disease	Van Buchem disease	FLNA GLB1	3.15e-03	17	146	2	C0432272
Disease	Meckel syndrome type 1	HYLS1 CC2D2A	3.53e-03	18	146	2	C3714506
Disease	Age-related macular degeneration	HMCN1 C3	3.53e-03	18	146	2	cv:C0242383
Disease	cystathionine measurement	TEC TEC	3.93e-03	19	146	2	EFO_0010474
Disease	Osteochondrodysplasias	FLNA GLB1	3.93e-03	19	146	2	C0029422
Disease	Dyschondroplasias	FLNA GLB1	3.93e-03	19	146	2	C0013366
Disease	Disorder of eye	PEX7 PCARE GRM6 CRB1 CC2D2A	4.16e-03	212	146	5	C0015397
Disease	Multiple Epiphyseal Dysplasia	FLNA GLB1	4.36e-03	20	146	2	C0026760
Disease	esophagus adenocarcinoma (is_implicated_in)	BIRC3 MMP1	4.80e-03	21	146	2	DOID:4914 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
FQKTHYPDVYVREQL	ALX1	151	Q15699
YLIVVGVIYNKGFLH	ADGRL4	516	Q9HBW9
LKELFEPYGAVYQIN	CELF2	56	O95319
YFPGAHRQVYKNLQE	CYP2B6	226	P20813
CIIYFNGEVPQLVLY	ADORA3	251	P0DMS8
GEHLVFKYNLRVPYG	ADAM7	151	Q9H2U9
IPQLLEHLFYESYQK	ABCA9	876	Q8IUA7
AQVVGVLKIQVHYYE	CAPZA1	186	P52907
HGRAYVPIAQVKDVY	GPNMB	216	Q14956
YVYIRHQGEVQNYKP	HTR3A	136	P46098
YQPGITYIVVQKRHH	AGO1	696	Q9UL18
IKQGHIPELQEYVKY	ASB15	51	Q8WXK1
FKVHQYFNVELIQPG	C3	1461	P01024
YFNVELIQPGAVKVY	C3	1466	P01024
LYEHLFVQQDIKYIP	BIRC3	521	Q13489
YKPIGFVNQLAVHYT	DNAI1	91	Q9UI46
KKYQEYIPVQTGAHA	DHX29	806	Q7Z478
HGPYYQTLAEIKKQI	ARMCX5	271	Q6P1M9
KELYYHGEPLNVNVH	ARRB2	206	P32121
VVQAYVGDVHYKEIP	ATP2B2	511	Q01814
LNQHKANEYYPVVLI	ADAMTS18	756	Q8TE60
DEVQKFLGVLPHYNY	NDST3	781	O95803
ESQPGFIQGYHVYLK	OSMR	651	Q99650
YVHYGEVVQLPLEFV	IPPK	71	Q9H8X2
GEKIYLYTHLKQQPI	KIAA0513	286	O60268
PHFSKPYYQVIVQEN	PCDH19	451	Q8TAB3
QYIHVTGTVFLQLPY	DEPDC5	1501	O75140
YHIVYKEGQFYPVNL	LARGE1	531	O95461
GNYIFQVIVNPHYEV	LOXL4	691	Q96JB6
IYLQDVQMVHPKFYG	GLIPR1L2	101	Q4G1C9
QFIHKYITYNAPAAI	INTS1	1961	Q8N201
PGFEKRLQLYQLFHY	FN3KRP	271	Q9HA64
YGKKFHVNYTQPLVA	ATP1B2	231	P14415
HLEFKVNYTDYIQPI	TMPRSS15	881	P98073
LQEQYAYEKPHVVCG	HERC1	3861	Q15751
QHAQYVGPYRLEKTL	BRSK2	11	Q8IWQ3
LYPLTFIQVKQHYGF	GLB1	401	P16278
IKQIAQPGAAYFYVE	CWF19L1	456	Q69YN2
LNIIDLQFLHGYYEP	CPSF1	201	Q10570
QYIHIFLANLYVVVP	OR52E6	271	Q96RD3
EVPFHLKAVYDNQYL	PCDH9	406	Q9HC56
AGPLQVYKEHAQEVY	PEX7	101	O00628
FYKHILGIPVNYQDV	HACE1	666	Q8IYU2
TEFQLLYVYHLVGPF	MED23	1241	Q9ULK4
KFHLQNTLYPQYDPV	NIPBL	1341	Q6KC79
VVYAIAFNNPYGDKI	DAW1	136	Q8N136
KLLNHPNVIEYYENF	NEK8	56	Q86SG6
YSVQGHRVKIYQPEG	KDM3B	196	Q7LBC6
YAVPEKIGQVHYALE	LNPEP	381	Q9UIQ6
TFLKNGEPYYILQHP	LMTK2	181	Q8IWU2
YVENPFFGQRYIHIL	PADI2	216	Q9Y2J8
IHDYLYFQVLSPGDI	PRADC1	26	Q9BSG0
YNPLYKERHQVQLLG	DDX23	286	Q9BUQ8
KHNIIPIFAVTNYSY	ITGB4	316	P16144
QIPLHLAAQYGHYEV	CASKIN2	116	Q8WXE0
KHGIYVQAINYPTVP	ALAS2	496	P22557
VQYYLAQHYDKIGQP	NAA15	376	Q9BXJ9
YIDKGQYLHIPRAQV	HMCN1	1596	Q96RW7
GVLFEIHYPEKYNVF	PTPRO	136	Q16827
IHYPEKYNVFTRVNI	PTPRO	141	Q16827
LEPPNFFQKYRHYIV	PAPOLG	361	Q9BWT3
YVHPNQVDFGNIYVL	HYDIN	806	Q4G0P3
QHIYVPNNYLVPTEK	HYLS1	256	Q96M11
YVPKTYVILFHPEQN	GRM6	836	O15303
VEFALAVYIHPYPKN	CC2D2A	1591	Q9P2K1
AEKQQQPPTVYLLHY	CABIN1	1216	Q9Y6J0
QNYARKYTIPIDHIG	DNAH3	3981	Q8TD57
PVVHEIAYQYGKNVG	PDSS1	286	Q5T2R2
DYSILVKYNEQHVPG	FLNA	1931	P21333
NYPKEQVESKPYFHV	FRMPD2	481	Q68DX3
VHISTPNKYEFQYVQ	CPAMD8	951	Q8IZJ3
HPYQPNEYLKALVAV	CPNE4	331	Q96A23
FKAYIKIYQGEELPH	ATL2	356	Q8NHH9
LHHVQNFQKYGPIYR	CYP11A1	76	P05108
QHAQYVGPYRLEKTL	BRSK1	26	Q8TDC3
QYSIQVAFHIQPYKG	MANEAL	216	Q5VSG8
YLSYFENVHGFINKP	CRB1	1106	P82279
VYQDPQGRHVKTYEV	DDB1	181	Q16531
YIKSQPIVFEVFGHY	KIF1A	1066	Q12756
VFTHNEYKFYVPENL	PCDH11Y	601	Q9BZA8
FPEPLVKAHQQAYTY	PCARE	176	A6NGG8
PVVYVKHQAQIDQYL	RTN1	736	Q16799
YGIPYTQIQELALHF	SYT4	226	Q9H2B2
FYQSLGIPYHIVNIV	SARS1	351	P49591
GEKFPLIEQTYYPNH	SYN2	241	Q92777
VQEKYQDGVYVLHPQ	SERAC1	371	Q96JX3
GVQPEHIQYLKNYFH	SMCHD1	326	A6NHR9
AYAHPQQKVAVYRAL	TRADD	31	Q15628
HHNQQVFGPYYAEIL	TCP11X2	376	Q5H9J9
NKYPFQVVHDANTLY	TEC	76	P42680
QYVYVDNNIHLKGLP	LRRC28	206	Q86X40
VQGQNVLHGYPKDIY	MMP1	351	P03956
FGEYVAEILPKYVQQ	NDUFS3	61	O75489
HLDPAVKEVQYNPTY	CDC40	71	O60508
TEYYPHLVFLQNKAR	SMG9	361	Q9H0W8
YLGFQVQKIYPFHDN	SMIM18	16	P0DKX4
AFHQGIYPELYSILE	SIX4	156	Q9UIU6
HYGYINVKTQEPLQL	ST6GALNAC3	61	Q8NDV1
YQKPEGNHIIKVGIY	SHPRH	201	Q149N8
PAKIHVFYIDYGNRE	SND1	756	Q7KZF4
YVFGDHPLIQFQYIR	PIK3CB	256	P42338
QLKHPSILELYNYFE	PLK4	66	O00444
YYNKNPGFEIIHGLL	FARSB	501	Q9NSD9
FIRVLQPYNKTHIYV	SEMA3D	131	O95025
SHQQYFYKIPILVIN	STEAP1	101	Q9UHE8
TSHQQYFYKIPILVI	STEAP1B	81	Q6NZ63
AIYFEKILPNEYGHR	ABCA8	416	O94911
VVYYHNIETSNFPKL	ABCC8	121	Q09428
SYHSYVIGFVVPNQK	ACSL3	616	O95573
VFYLFEPLYHVQNTL	CHST1	86	O43916
EKDYQVLVFYHSPVA	PLCXD3	186	Q63HM9
NTGPLVYVLYAVLVH	USP17L3	311	A6NCW0
NTGPLVYVLYAVLVH	USP17L4	311	A6NCW7
APEFAQELQLYGHIY	UROC1	61	Q96N76
QYEIVDYLGPRKHFI	STPG1	271	Q5TH74
YGGIPAFIHAKQQYI	TIMMDC1	91	Q9NPL8
NTGPLVYVLYAVLVH	USP17L18	311	D6R9N7
EIYVPIKQFFYNLIH	PIEZO2	2166	Q9H5I5
NTGPLVYVLYAVLVH	USP17L5	311	A8MUK1
NTGPLVYVLYAVLVH	USP17L21	311	D6R901
NTGPLVYVLYAVLVH	USP17L13	311	C9JLJ4
DVHQVYKYPFEQVVA	PRELID2	6	Q8N945
YFEKNVQGIVPRSYH	SGMS1	376	Q86VZ5
EFPHKLYIQNYTSAV	SNX27	336	Q96L92
NTGPLVYVLYAVLVH	USP17L19	311	D6RCP7
INVEVKHGGFVYYQE	PREPL	111	Q4J6C6
NTGPLVYVLYAVLVH	USP17L1	311	Q7RTZ2
HLPELQLFQYEGKIY	ZNF347	191	Q96SE7
QRYPGYFKVDHIKGI	ZNF658	76	Q5TYW1
DPEHFNYIVKLLYQV	TOPAZ1	1236	Q8N9V7
NTGPLVYVLYAVLVH	USP17L12	311	C9JPN9
YIHENYLQLFEFVGK	UBE3B	766	Q7Z3V4
AYIKQQGIHFREKPY	ZNF655	366	Q8N720
KHVDAQGRIYLPYLQ	UEVLD	101	Q8IX04
NTGPLVYVLYAVLVH	USP17L24	311	Q0WX57
IQFNKHLLSTYYVPG	ZNF74	586	Q16587
NTGPLVYVLYAVLVH	USP17L7	311	P0C7H9
NTGPLVYVLYAVLVH	USP17L8	311	P0C7I0
VVINYNHKFIENIGY	TRPC6	691	Q9Y210
NHKFIENIGYVLYGV	TRPC6	696	Q9Y210
NTGPLVYVLYAVLVH	USP17L6P	311	Q6QN14
VQYPGQHLQLLLKYF	TRAV8-1	56	A0A0A6YYK1
NTGPLVYVLYAVLVH	USP17L22	311	D6RA61
LHQYSKAPVYLFEQV	UBR4	866	Q5T4S7
NSGPLVYVLYAVLVH	USP17L15	311	C9J2P7
NTGPLVYVLYAVLVH	USP17L17	311	D6RBQ6
INRKVQLTYYPHGVK	PPIP5K1	486	Q6PFW1
NTGPLVYVLYAVLVH	USP17L2	311	Q6R6M4
KNIHVDPPFLYKYQQ	VWA3A	466	A6NCI4
NTGPLVYVLYAVLVH	USP17L20	311	D6RJB6
VYKAVGHYNVAIPSD	TMEM39B	391	Q9GZU3
NTGPLVYVLYAVLVH	USP17L10	311	C9JJH3
NTGPLVYVLYAVLVH	USP17L11	311	C9JVI0
PIHPIINNFVRYYNK	KCNF1	401	Q9H3M0
YGQHPNIITLKDVYD	RPS6KA1	466	Q15418
AISIFHYAKGQPYID	MPZ	76	P25189